(Q48255417)

10 February 2018

title

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. (English)

1 reference

10 February 2018

0 references

2

C Halldin

1 reference

10 February 2018

author name string

L Farde

series ordinal

1

1 reference

10 February 2018

S Stone-Elander

series ordinal

3

1 reference

10 February 2018

G Sedvall

series ordinal

4

1 reference

10 February 2018

publication date

1 January 1987

1 reference

10 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 February 2018

volume

92

1 reference

10 February 2018

page(s)

278-284

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00210831

exact match

0 references

cites work

D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390.

1 reference

12 December 2020

Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat.

1 reference

12 December 2020

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

1 reference

12 December 2020

3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors

1 reference

12 December 2020

A sensitive and specific radioimmunoassay for CIS (Z)- flupenthixol in human serum

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

12 December 2020

Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate

1 reference

12 December 2020

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

The Classification of Dopamine Receptors: Relationship to Radioligand Binding

1 reference

12 December 2020

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

1 reference

12 December 2020

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

1 reference

12 December 2020

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

1 reference

12 December 2020

Imaging of neurotransmitter receptors in the living human brain

1 reference

12 December 2020

Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography

1 reference

12 December 2020

Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature

1 reference

12 December 2020

Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors

1 reference

12 December 2020

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

[3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system.

1 reference

12 December 2020

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

12 December 2020

Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats

1 reference

12 December 2020

Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.

1 reference

12 December 2020

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

12 December 2020

Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.

1 reference

12 December 2020

Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain

1 reference

12 December 2020

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00210831

1 reference

10 February 2018

PubMed ID

2957716

1 reference

10 February 2018